Trial Profile
Thalidomide for Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2012
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Smoldering multiple myeloma
- Focus Adverse reactions
- 03 Dec 2010 New trial record